×
About 4,270 results

ALLMedicine™ Anthrax Center

Research & Reviews  856 results

Case-control study of human anthrax outbreak investigation in farta woreda, South Gonda...
https://doi.org/10.1186/s12879-023-08136-9
BMC Infectious Diseases; Wondmnew T, Asrade B

Mar 19th, 2023 - Anthrax is a zoonotic disease caused by the Bacillus anthracis bacteria, which is one of the top five important livestock diseases and the second top priority zoonotic disease, next to rabies, in Ethiopia, which remains a major problem for animals...

Efficacy of ANTHRASIL (Anthrax Immune Globulin Intravenous (Human)) in rabbit and nonhu...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10022752
PloS One; Kammanadiminti S, Comer J et. al.

Mar 18th, 2023 - To meet the requirements of the Animal Rule, the efficacy of monotherapy with ANTHRASIL® (Anthrax Immune Globulin Intravenous (Human)) for inhalational anthrax was evaluated in blinded studies using rabbit and nonhuman primate models. Animals in b...

Inhalable vaccine of bacterial culture supernatant extract mediates protection against ...
https://doi.org/10.1080/22221751.2023.2191741
Emerging Microbes & Infections; Zhai LN, Zhao Y et. al.

Mar 16th, 2023 - AbstractPulmonary anthrax is the most fatal clinical form of anthrax and currently available injectable vaccines do not provide adequate protection against it. Hence, next-generation vaccines that effectively induce immunity against pulmonary anth...

Anthrax AV7909 Liquid vs Lyophilized
https://clinicaltrials.gov/ct2/show/NCT04660201

Mar 10th, 2023 - This is a randomized, parallel-group, double-blind, Phase 1 study designed to assess safety, tolerability and immunogenicity of 2 formulations of adjuvanted anthrax vaccine (AV7909), lyophilized and liquid. Forty healthy young adults, 18 to 45 yea...

Observational Study Evaluating Clinical Benefit and Safety of AIGIV (ANTHRASIL®) in Patients With Systemic Anthrax
https://clinicaltrials.gov/ct2/show/NCT03569514

Mar 9th, 2023 - This study is a post-marketing requirement from the FDA to evaluate safety and clinical benefit of AIGIV administered to systemic anthrax patients as part of their medical care after exposure to Bacillus anthracis (anthrax exposure can be via inha...

see more →

Guidelines  3 results

Doctors Still Overprescribing Fluoroquinolones Despite Risks
https://www.medscape.com/viewarticle/976602?src=
Medscape Tate N.

Jul 5th, 2022 - When Amy Moser had a simple urinary tract infection in her late 20s, her doctor prescribed Cipro, a powerful antibiotic used to treat anthrax and some of the most fearsome bacterial infections. Nearly 2 weeks after she finished her treatment, h...

Use of Anthrax Vaccine in the United States: Recommendations of the Advisory Committee ...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6918956
MMWR. Recommendations and Reports : Morbidity and Mortali... Bower WA, Schiffer J et. al.

Dec 14th, 2019 - This report updates the 2009 recommendations from the CDC Advisory Committee on Immunization Practices (ACIP) regarding use of anthrax vaccine in the United States (Wright JG, Quinn CP, Shadomy S, Messonnier N. Use of anthrax vaccine in the United...

Use of anthrax vaccine in the United States: recommendations of the Advisory Committee ...
https://www.ncbi.nlm.nih.gov/pubmed/20651644
MMWR. Recommendations and Reports : Morbidity and Mortali... Wright JG, Quinn CP et. al.

Jul 24th, 2010 - These recommendations from the Advisory Committee on Immunization Practices (ACIP) update the previous recommendations for anthrax vaccine adsorbed (AVA) (CDC. Use of anthrax vaccine in the United States: Recommendations of the Advisory Committee ...

see more →

Drugs  633 results see all →

Clinicaltrials.gov  44 results

Anthrax AV7909 Liquid vs Lyophilized
https://clinicaltrials.gov/ct2/show/NCT04660201

Mar 10th, 2023 - This is a randomized, parallel-group, double-blind, Phase 1 study designed to assess safety, tolerability and immunogenicity of 2 formulations of adjuvanted anthrax vaccine (AV7909), lyophilized and liquid. Forty healthy young adults, 18 to 45 yea...

Observational Study Evaluating Clinical Benefit and Safety of AIGIV (ANTHRASIL®) in Patients With Systemic Anthrax
https://clinicaltrials.gov/ct2/show/NCT03569514

Mar 9th, 2023 - This study is a post-marketing requirement from the FDA to evaluate safety and clinical benefit of AIGIV administered to systemic anthrax patients as part of their medical care after exposure to Bacillus anthracis (anthrax exposure can be via inha...

A Field Study Evaluating Clinical Benefit and Safety of AIGIV (ANTHRASIL®) in Inhalational Anthrax Patients
https://clinicaltrials.gov/ct2/show/NCT03569553

Mar 8th, 2023 - This study is a post-marketing requirement from the FDA to evaluate safety and clinical benefit of AIGIV administered to patients as part of their medical care after inhalational exposure to Bacillus anthracis. Study information (i.e. data on safe...

Natural History of Anthrax: a Study of Primary Infected, Recovered, and Exposed Individuals (SPoRE); and Evaluation of AVA-Vaccinated Recipients
https://clinicaltrials.gov/ct2/show/NCT00050310

Feb 21st, 2023 - The intentional use of Bacillus anthracis in 2001 as a bioterrorism weapon with fatal consequences renewed interest in past epidemiologic and animal research about pathogenesis and posed new dilemmas about diagnosis and treatment. Cases in the Oct...

Velocity 2: An Anthrax Vaccine and Antibiotics Clinical Study
https://clinicaltrials.gov/ct2/show/NCT04067011

Feb 3rd, 2023 - This is a Phase 2, open-label, multicenter, randomized trial designed to evaluate the pharmacokinetic profile, immunogenicity, and safety of AV7909 and ciprofloxacin or doxycycline when administered concomitantly in healthy adults for an indicatio...

see more →

News  161 results

China May Announce 10 New COVID Easing Steps on Wednesday: Sources
https://www.medscape.com/viewarticle/984972

Dec 6th, 2022 - HONG KONG (Reuters) - China may announce 10 new COVID-19 easing measures as early as Wednesday, two sources with knowledge of the matter told Reuters, supplementing 20 unveiled in November that set off a wave of COVID easing steps nationwide. Thre...

Doctors Still Overprescribing Fluoroquinolones Despite Risks
https://www.medscape.com/viewarticle/976602?src=
Medscape Tate N.

Jul 5th, 2022 - When Amy Moser had a simple urinary tract infection in her late 20s, her doctor prescribed Cipro, a powerful antibiotic used to treat anthrax and some of the most fearsome bacterial infections. Nearly 2 weeks after she finished her treatment, h...

Doctors Still Overprescribing Fluoroquinolones Despite Risks
https://www.medscape.com/viewarticle/976602

Jul 5th, 2022 - When Amy Moser had a simple urinary tract infection in her late 20s, her doctor prescribed Cipro, a powerful antibiotic used to treat anthrax and some of the most fearsome bacterial infections. Nearly 2 weeks after she finished her treatment, her ...

Simple Disinfectant Made From Sawdust Destroys Deadly Microbes
https://www.medscape.com/viewarticle/966973

Jan 20th, 2022 - Some of the world's deadliest microbes are proving no match for a new sustainable disinfectant made from sawdust and water, according to researchers who were looking for environmentally friendly alternatives to chlorine cleaning products. What to ...

Potential Military Vaccine Mandate Brings Distrust, Support
https://www.medscape.com/viewarticle/956172

Aug 6th, 2021 - Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. SAN DIEGO (AP) — Since President Joe Biden asked the Pentagon last week to look at adding the COVID-19 vaccine to the military's mandatory shots, ...

see more →

Patient Education  11 results see all →